clenbuterol has been researched along with Hypokalemia in 6 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol is a long acting beta2-adrenergic agonist used in the treatment of pulmonary disorders." | 5.31 | Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. ( Freyberg, CL; Hoffman, RJ; Hoffman, RS; Nelson, LS; Poppenga, RH, 2001) |
| "Clenbuterol is an oral β2-agonist with anabolic and lipolytic effects that is misused as a performance and image enhancing drug." | 1.56 | Clenbuterol: a new toxic substance in paediatrics. ( Logan, S; McKie, A; Pollock, L; Tester, AA, 2020) |
| "Clenbuterol is a long acting beta2-adrenergic agonist used in the treatment of pulmonary disorders." | 1.31 | Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels. ( Freyberg, CL; Hoffman, RJ; Hoffman, RS; Nelson, LS; Poppenga, RH, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Tester, AA | 1 |
| Logan, S | 1 |
| Pollock, L | 1 |
| McKie, A | 1 |
| DuBrock, HM | 1 |
| Clardy, PF | 1 |
| Nawrocka, I | 1 |
| Kowalczys, MH | 1 |
| Abramczyk, P | 1 |
| Dimaano, JQ | 1 |
| Burda, AM | 1 |
| Korah, JE | 1 |
| Wahl, M | 1 |
| Hoffman, RJ | 1 |
| Hoffman, RS | 1 |
| Freyberg, CL | 1 |
| Poppenga, RH | 1 |
| Nelson, LS | 1 |
6 other studies available for clenbuterol and Hypokalemia
| Article | Year |
|---|---|
Clenbuterol: a new toxic substance in paediatrics.
Topics: Acidosis; Adolescent; Adrenergic beta-Agonists; Chest Pain; Clenbuterol; Diagnosis, Differential; El | 2020 |
Palpitations, hypotension, hypokalemia, and hyperlactatemia. Putting the pieces together.
Topics: Adrenergic beta-Agonists; Clenbuterol; Diagnosis, Differential; Electrocardiography; Humans; Hyperla | 2014 |
Acute clenbuterol overdose manifestations in a suicide attempt--a case report.
Topics: Adult; Clenbuterol; Drug Overdose; Humans; Hypokalemia; Male; Suicide, Attempted; Tachycardia, Sinus | 2015 |
Street drugs possibly tainted with clenbuterol.
Topics: Adrenergic beta-Agonists; Adult; Clenbuterol; Diagnosis, Differential; Drug Contamination; Heroin; H | 2008 |
Atypical reactions associated with heroin use--five states, January-April 2005.
Topics: Adrenergic beta-Agonists; Adult; Clenbuterol; Connecticut; Heroin Dependence; Humans; Hypokalemia; H | 2005 |
Clenbuterol ingestion causing prolonged tachycardia, hypokalemia, and hypophosphatemia with confirmation by quantitative levels.
Topics: Adrenergic beta-Agonists; Adult; Clenbuterol; Electrocardiography; Enzyme-Linked Immunosorbent Assay | 2001 |